证券代码：605388 证券简称：均瑶健康 公告编号：2025-055 根据《公司法》《公司章程》等有关规定，上述辞职报告自送达董事会之日 起生效。蒋海龙先生已按照公司相关规定做好交接工作，不存在未履行完毕的公 开承诺，其离任公司非独立董事职务不会导致公司董事会成员人数低于法定人数， 不会影响公司正常的经营发展。 蒋海龙先生在担任公司非独立董事期间，始终恪尽职守、勤勉尽责，公司董 事会对其为公司发展所做出的贡献表示衷心地感谢！ 关于非独立董事辞职暨选举职工董事、补选董事会 专门委员会委员的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、董事离任情况 | | | | 姓名 | 离任职务 | 离任时间 | | 原定任期 到期日 | | 离任原因 | 是否继续在上 市公司及其控 | 具体职务 | 是否存在 未履行完 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | 股子公司任职 | （如适用） | ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：605388 证券简称：均瑶健康 公告编号：2025-057 湖北均瑶大健康饮品股份有限公司 关于召开2025年第三次临时股东会的通知 一、 召开会议的基本情况 (一)股东会类型和届次 2025年第三次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 10 月 29 日 14 点 00 分 召开地点：上海市浦东新区康桥东路 2 弄 1 号楼大会议室 (五)网络投票的系统、起止日期和投票时间。 股东会召开日期：2025年10月29日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 10 月 29 日 至2025 年 10 月 29 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段 ...

证券代码：605388 证券简称：均瑶健康 公告编号：2025-053 湖北均瑶大健康饮品股份有限公司 1 二、监事会会议审议情况 （一）审议通过《关于取消监事会并修订<公司章程>的议案》 监事会认为：公司取消监事会并修订《公司章程》符合《公司法》等相关 规定，符合公司实际情况，不会影响公司正常生产经营，不存在损害公司及股东 利益的情形。监事会同意取消监事会并修订《公司章程》。 具体内容详见公司同日披露的《湖北均瑶大健康饮品股份有限公司关于取 消监事会并修订<公司章程>、新增及修订公司部分治理制度的公告》（公告编 号：2025-054）。 表决结果：同意：3 票，反对：0 票，弃权：0 票。 此议案尚需提交股东大会审议。 第四届监事会第十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 湖北均瑶大健康饮品股份有限公司（以下简称"公司"）第四届监事会第 十三次会议于 2025 年 10 月 10 日下午在公司会议室以现场会议方式召开，本次 会议通知于 2025 年 9 月 30 日以电子邮 ...

证券代码：605388 证券简称：均瑶健康 公告编号：2025-047 湖北均瑶大健康饮品股份有限公司 第五届董事会第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 湖北均瑶大健康饮品股份有限公司（以下简称"公司"）第五届董事会第 十七次会议于 2025 年 10 月 10 日下午在公司会议室以现场结合通讯会议方式召 开，本次会议通知于 2025 年 9 月 30 日以电子邮件形式送达公司全体董事。本次 会议由公司董事长王均豪先生主持。会议应出席董事 9 人，实际出席董事 9 人， 公司监事和高级管理人员列席了本次会议。本次会议的召开符合《公司法》和《公 司章程》等有关规定。 二、董事会会议审议情况 （一）审议通过《关于取消监事会并修订<公司章程>的议案》 为进一步完善公司治理结构，更好地促进公司规范运作，公司董事会同意 取消监事会，《监事会议事规则》相应废止，并对《公司章程》部分条款进行修 订。 具体内容详见公司同日披露的《湖北均瑶大健康饮品股份有限公司关于取 消监事会并修订<公司 ...

Core Insights - The beverage and dairy sector experienced a rise of 0.66% on October 9, with Zhuangyuan Pastoral leading the gains [1] - The Shanghai Composite Index closed at 3933.97, up 1.32%, while the Shenzhen Component Index closed at 13725.56, up 1.47% [1] Sector Performance - Zhuangyuan Pastoral (002910) closed at 10.86, with a significant increase of 10.03%, trading volume of 239,000 shares, and a transaction value of 254 million [1] - Qiaoyuan Beverage (603156) saw a rise of 6.18%, closing at 31.29, with a trading volume of 328,100 shares and a transaction value of 1.042 billion [1] - Panda Dairy (300898) increased by 1.79%, closing at 26.09, with a trading volume of 30,800 shares and a transaction value of 79.09 million [1] - Yili Group (600887) rose by 1.28%, closing at 27.63, with a trading volume of 711,500 shares and a transaction value of 1.94 billion [1] - Tianrun Dairy (600419) and Beingmate (002570) also showed modest increases of 1.18% and 1.13%, respectively [1] Capital Flow - The beverage and dairy sector saw a net inflow of 47.31 million from institutional investors, while retail investors experienced a net outflow of 1.09 billion [2] - The sector's overall capital flow indicates a strong interest from institutional and speculative investors, despite the outflow from retail investors [2]

Market Overview - The beverage and dairy sector increased by 0.9% on September 29, with Yangyuan Beverage leading the gains [1] - The Shanghai Composite Index closed at 3862.53, up 0.9%, while the Shenzhen Component Index closed at 13479.43, up 2.05% [1] Stock Performance - Key stocks in the beverage and dairy sector showed varied performance, with notable gainers including: - Chi Yuan Beverage (603156) at 30.30, up 7.68% with a trading volume of 446,200 shares and a turnover of 1.337 billion [1] - Dongpeng Beverage (605499) at 290.55, up 1.75% with a trading volume of 16,700 shares and a turnover of 480 million [1] - Other stocks like Zhuangyuan Pasture (002910) and Huangshi Group (002329) also saw modest increases of 1.47% and 1.13% respectively [1] Capital Flow - The beverage and dairy sector experienced a net outflow of 224 million from institutional investors, while retail investors saw a net inflow of 135 million [2] - Notable capital flows included: - Institutional net inflow for Dongpeng Beverage at 56.24 million, while retail saw a net outflow of 55.29 million [3] - Bright Dairy (600597) had a net inflow of 9.92 million from institutional investors, with retail outflows totaling 8.16 million [3]

Core Viewpoint - Junyao Health's stock price has experienced fluctuations, with a year-to-date increase of 29.10% but a recent decline over the past five trading days of 9.38% [1] Group 1: Stock Performance - As of September 18, Junyao Health's stock price was 8.02 CNY per share, with a market capitalization of 4.816 billion CNY [1] - The stock has seen a net outflow of 9.8116 million CNY in principal funds, with significant selling pressure [1] - The company has appeared on the trading leaderboard 11 times this year, with the most recent occurrence on June 13 [1] Group 2: Financial Performance - For the first half of 2025, Junyao Health reported a revenue of 766 million CNY, reflecting a year-on-year growth of 1.38% [2] - The net profit attributable to shareholders was 7.4661 million CNY, showing a significant decline of 78.52% year-on-year [2] Group 3: Business Overview - Junyao Health specializes in the research, production, and sales of ambient lactic acid bacteria beverages, with a revenue composition of 34.11% from probiotic drinks, 34.07% from supply chain, 21.98% from probiotic foods, and 9.55% from other beverages and foods [1] - The company is categorized under the food and beverage industry, specifically in the dairy sector, and is involved in various concepts such as plant protein and domestic dairy [2] Group 4: Shareholder Information - As of June 30, 2025, Junyao Health had 42,700 shareholders, an increase of 58.20% from the previous period [2] - The top ten circulating shareholders include Tianhong Zhongzheng Food and Beverage ETF, which holds 831,800 shares as a new shareholder [3]

Core Viewpoint - Junyao Health has successfully entered the markets of over 80 countries and regions with its probiotic products, attributed to continuous investment in product research and international expansion [2] Group 1: Market Presence - The company has established a presence in over 80 countries and regions globally with its probiotic products [2] Group 2: Research and Development - Continuous investment in product research and international layout has been a key factor in the company's success [2] Group 3: Collaboration and Partnerships - The company maintains an open cooperation attitude and actively engages with industry leaders worldwide [2] - Specific details of some commercial collaborations are not disclosed due to related agreements [2] - The company aims to explore win-win cooperation models with internationally renowned enterprises in the future [2]

（文章来源：证券日报） 证券日报网讯均瑶健康9月9日在互动平台回答投资者提问时表示，关于Akk菌的药品级应用，公司将基 于科学研究的成熟度、相关法规政策要求及自身战略发展规划进行综合评估。未来，若有相关技术转化 或业务布局，公司将严格按照信息披露规则及时向市场公开。当前，公司仍将以现有核心菌株的产业化 应用为重点，持续强化研发投入与技术创新，为消费者提供安全、有效的益生菌产品及服务。 ...

证券日报网讯 均瑶健康9月9日在互动平台回答投资者提问时表示，均瑶健康始终聚焦益生菌技术与健 康食品的创新融合，子公司均瑶润盈自主研发的AKKBG-001™凭借成熟的灭活技术，已攻克液态载体 中益生菌稳定性的行业难题，其经全基因组测序验证的安全性及肠道健康调节等功能属性，与天然健康 的食品定位高度契合。公司在益生菌应用领域已有多元实践，不仅推出含专利菌株的益生菌乳饮品等终 端产品，还通过"酸奶伴侣"等创新形态探索菌株与乳制品的结合模式，积累了丰富的应用经验。 （编辑 任世碧） ...